517 related articles for article (PubMed ID: 27288475)
21. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
[TBL] [Abstract][Full Text] [Related]
22. Two-year efficacy and safety of relugolix combination therapy in women with endometriosis-associated pain: SPIRIT open-label extension study.
Becker CM; Johnson NP; As-Sanie S; Arjona Ferreira JC; Abrao MS; Wilk K; Imm SJ; Mathur V; Perry JS; Wagman RB; Giudice LC
Hum Reprod; 2024 Mar; 39(3):526-537. PubMed ID: 38243752
[TBL] [Abstract][Full Text] [Related]
23. Measurement of changes in uterine and fibroid volume during treatment of heavy menstrual bleeding (HMB).
Yin K; Whitaker L; Hojo E; McLenachan S; Walker J; McKillop G; Stubbs C; Priest L; Cruz M; Roberts N; Critchley H
Hum Reprod Open; 2023; 2023(3):hoad021. PubMed ID: 37304815
[TBL] [Abstract][Full Text] [Related]
24. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
Swahn ML; Johannisson E; Daniore V; de la Torre B; Bygdeman M
Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630
[TBL] [Abstract][Full Text] [Related]
25. A first-in-human study of PDC31 (prostaglandin F2α receptor inhibitor) in primary dysmenorrhea.
Böttcher B; Laterza RM; Wildt L; Seufert RJ; Buhling KJ; Singer CF; Hill W; Griffin P; Jilma B; Schulz M; Smith RP
Hum Reprod; 2014 Nov; 29(11):2465-73. PubMed ID: 25164021
[TBL] [Abstract][Full Text] [Related]
26. Paracervical block as pain treatment during second-trimester medical termination of pregnancy: an RCT with bupivacaine versus sodium chloride.
Andersson IM; Benson L; Christensson K; Gemzell-Danielsson K
Hum Reprod; 2016 Jan; 31(1):67-74. PubMed ID: 26573530
[TBL] [Abstract][Full Text] [Related]
27. BAY 1002670: a novel, highly potent and selective progesterone receptor modulator for gynaecological therapies.
Wagenfeld A; Bone W; Schwede W; Fritsch M; Fischer OM; Moeller C
Hum Reprod; 2013 Aug; 28(8):2253-64. PubMed ID: 23739217
[TBL] [Abstract][Full Text] [Related]
28. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
Modesto W; Bahamondes MV; Bahamondes L
Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
[TBL] [Abstract][Full Text] [Related]
29. Single- and Multiple-Dose Pharmacokinetics and Safety of Vilaprisan in Healthy Postmenopausal Japanese Women: A Randomized Clinical Trial.
Schultze-Mosgau MH; Matsuki S; Okumura K; Kaneko M
Eur J Drug Metab Pharmacokinet; 2022 Jan; 47(1):49-56. PubMed ID: 34635989
[TBL] [Abstract][Full Text] [Related]
30. Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial.
Glund S; Stangier J; Schmohl M; Gansser D; Norris S; van Ryn J; Lang B; Ramael S; Moschetti V; Gruenenfelder F; Reilly P; Kreuzer J
Lancet; 2015 Aug; 386(9994):680-90. PubMed ID: 26088268
[TBL] [Abstract][Full Text] [Related]
31. Vilaprisan, a New Selective Progesterone Receptor Modulator in Uterine Fibroid Pharmacotherapy-Will it Really be a Breakthrough?
Ciebiera M; Vitale SG; Ferrero S; Vilos GA; Barra F; Caruso S; Laganà AS; Sierant A; Cianci A; Jakiel G
Curr Pharm Des; 2020; 26(3):300-309. PubMed ID: 31985366
[TBL] [Abstract][Full Text] [Related]
32. Induction of post-menstrual regeneration by ovarian steroid withdrawal in the functionalis of xenografted human endometrium.
Coudyzer P; Lemoine P; Po C; Jordan BF; Van Der Smissen P; Courtoy PJ; Henriet P; Marbaix E
Hum Reprod; 2015 May; 30(5):1156-68. PubMed ID: 25750204
[TBL] [Abstract][Full Text] [Related]
33. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
Kisicki JC; Fiske K; Lyne A
Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
[TBL] [Abstract][Full Text] [Related]
34. A feasibility trial of screening women with idiopathic recurrent miscarriage for high uterine natural killer cell density and randomizing to prednisolone or placebo when pregnant.
Tang AW; Alfirevic Z; Turner MA; Drury JA; Small R; Quenby S
Hum Reprod; 2013 Jul; 28(7):1743-52. PubMed ID: 23585559
[TBL] [Abstract][Full Text] [Related]
35. Endometrial inflammasome activation accompanies menstruation and may have implications for systemic inflammatory events of the menstrual cycle.
Azlan A; Salamonsen LA; Hutchison J; Evans J
Hum Reprod; 2020 Jun; 35(6):1363-1376. PubMed ID: 32488243
[TBL] [Abstract][Full Text] [Related]
36. Vilaprisan for treating uterine fibroids.
Melis GB; Neri M; Piras B; Paoletti AM; Ajossa S; Pilloni M; Marotto MF; Corda V; Saba A; Giancane E; Mais V
Expert Opin Investig Drugs; 2018 May; 27(5):497-505. PubMed ID: 29718788
[TBL] [Abstract][Full Text] [Related]
37. Recombinant human granulocyte- colony stimulating factor in women with unexplained recurrent pregnancy losses: a randomized clinical trial.
Eapen A; Joing M; Kwon P; Tong J; Maneta E; De Santo C; Mussai F; Lissauer D; Carter D;
Hum Reprod; 2019 Mar; 34(3):424-432. PubMed ID: 30776296
[TBL] [Abstract][Full Text] [Related]
38. Feasibility and effectiveness of unintended pregnancy prevention with low-dose mifepristone combined with misoprostol before expected menstruation.
Li CL; Chen DJ; Deng YF; Song LP; Mo XT; Liu KJ
Hum Reprod; 2015 Dec; 30(12):2794-801. PubMed ID: 26405260
[TBL] [Abstract][Full Text] [Related]
39. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
[TBL] [Abstract][Full Text] [Related]
40. Dietary factors and luteal phase deficiency in healthy eumenorrheic women.
Andrews MA; Schliep KC; Wactawski-Wende J; Stanford JB; Zarek SM; Radin RG; Sjaarda LA; Perkins NJ; Kalwerisky RA; Hammoud AO; Mumford SL
Hum Reprod; 2015 Aug; 30(8):1942-51. PubMed ID: 26082480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
